14h
GlobalData on MSNAI ethics: what are the limits in healthcare?Medical Device Network sits down with David Leslie of the Alan Turing Institute to understand what, if any, rules AI should ...
The paper reviews some of the major issues that occur in the application of big data analytics and predictive modeling in ...
In addition to Preliminary Accreditation by the LCME, Roseman has also secured approval from the Northwest Commission on ...
Funding freezes, legal fights, chaos — no one in medical research knows what will come, except that as of January 22, 2025, ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
18h
News Medical on MSNStudy highlights the need for more diversity in vaginal microbiome researchThis study emphasizes the need for global equity in vaginal microbiome research, addressing health disparities and improving ...
Shepherd University’s athletes will soon be some of the subjects of a new study being conducted by Photobiomodulation (PBM) ...
The integration of artificial intelligence (AI) in public health is driving transformative advancements in disease prevention ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
In honor of Black History Month, we're covering five milestones in Black health history, from the good and great to the bad and ...
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results